Frederic Chevessier

Angestellt, Director Molecular Therapeutics R&D/Preclinical development, CureVac
Tübingen, Deutschland

Fähigkeiten und Kenntnisse

Forschung und Entwicklung (F&E)
Preclinical Development Broad Rare Diseases/ Cross-functional Leadership
Project management
Wissenschaftliche Forschung
Wissenschaftliche Recherche

Werdegang

Berufserfahrung von Frederic Chevessier

  • Bis heute 10 Jahre und 6 Monate, seit März 2016

    Director Molecular Therapeutics R&D/Preclinical development

    CureVac

    Lead discovery and preclinical development of mRNA-based therapeutics, with focus on "rare" disorders including neuromuscular disorders- liver & ophthalmic diseases, now focused on immunology. Oversee cross-functional teams spanning protein design, mRNA engineering, LNP formulation, and in-vivo Proof of Principles Drive program strategy from target selection through preclinical proof-of-concept and IND-enabling activities Ensure regulatory-ready data packages (IND) and alignment with GxP and eQMS standards

  • 4 Jahre und 4 Monate, März 2018 - Juni 2022

    Associate Director Molecular therapeutics R&D/ preclinical

    CureVac

    Advanced mRNA therapeutic candidates through preclinical evaluation, including in vitro and in vivo models Designed and interpreted Protein-replacement Therapy-Gene Therapy- Immunogenicity studies Contributed to translational strategy and candidate selection Coordinated cross-functional activities across formulation, analytics, R&D, CMC Supported regulatory documentation and scientific reporting for development programs

  • 2 Jahre und 1 Monat, März 2016 - März 2018

    Scientist Enabling Technologies

    CureVac

    Developed and implemented novel assays and platforms for mRNA expression and characterization Multiple Proof of principles studies on the use of RNA Therapeutics in different pathologies. Established in vitro and cell-based systems to support candidate screening and selection Contributed to technology development for LNP-based delivery systems

  • 3 Jahre und 10 Monate, März 2012 - Dez. 2015

    Principal Researcher

    Medical University of Erlangen

    Led research programs on protein aggregation diseases (muscle and neurodegenerative diseases) Designed and executed mechanistic studies in cellular and animal models Supervised students and junior researchers Published scientific findings and contributed to grant applications

  • 5 Jahre und 8 Monate, Aug. 2005 - März 2011

    Postdoctoral Research Fellow

    Max Planck Institute for Medical Research

    Investigated neuromuscular disorders, including congenital myasthenic syndromes (AChR-MuSK) Generated and characterized animal models using embryonic stem cells and homologous recombination Studied neuromuscular junction biology and disease mechanisms

  • 3 Jahre und 9 Monate, Okt. 2001 - Juni 2005

    Promotion

    Institut de Myologie

    Focus on congenital myasthenic syndromes and congenital muscle diseases Conducted patient stratification and gene identification studies in different neuromuscular diseases (Musk-Agrin-Calsequestrin-STIM-ORA) Developed primary and co-culture systems (nerve–muscle models)

  • 10 Monate, Sep. 2000 - Juni 2001

    Master

    Pierre and Marie Curie University

    Specialized training in molecular biology and oncology Research project on leiomyosarcoma (Cochin Hospital, Paris)

XING – Das Jobs-Netzwerk

  • Über eine Million Jobs

    Entdecke mit XING genau den Job, der wirklich zu Dir passt.

  • Persönliche Job-Angebote

    Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.

  • 21 Mio. Mitglieder

    Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.

  • Kostenlos profitieren

    Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.

21 Mio. XING Mitglieder, von A bis Z